Log In
BCIQ
Print this Print this
 

HVJ-E (GEN0101, TSD-0014)

  Manage Alerts
Collapse Summary General Information
Company Ishihara Sangyo Kaisha Ltd.
DescriptionImmunotherapeutic drug that activates dendritic cells
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today